U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07951684) titled 'Streptococcus Salivarius Evol12(R) in Improving Quality of Life in Locally Advanced Head and Neck Cancer Treated With Radio(Chemo)Therapy: SMILE' on Nov. 04.
Brief Summary: The clinical study will involve the use of a dietary supplement based on the oral probiotic strain Streptococcus salivarius Evol12(R) in patients with head and neck cancer undergoing radiochemotherapy, with the aim of improving their quality of life. The hypothesis is that, as already outlined in scientific literature, modifying the oral microbiota through the use of the commensal S. salivarius, increasing its concentration and reducing the main pathogens in the ...